Yeah, I, I think from a, from a medical standpoint, you, you really want to know the status of the population that the animal is coming from as well as the one that it’s going to. And, and that’s been a, a big change. We don’t, we don’t always quarantine animals anymore when they’re coming from one zoo to another. Rather we do a risk assessment where we look at, again, those two populate where an animal’s coming from, where it’s going, if they’ve, if they’re positive for a particular parasite that is relatively innocuous, if that parasite exists to the same level in both places, that may not be a big deal. So, so those are, those are really some of the things that we look at is making sure that we’re not moving some disease organism from one place to another, or taking an animal that’s naive to a particular problem and introducing them to a place where eventually when they’re integrated into the group, they’re gonna be challenged by something that they haven’t faced before. The our our ability to do a, a much greater array of molecular diagnostic tests and other things to try and do those assessments, and particularly as medical care and pathology have improved across the board, we, we get, we get a much better ability to, to assess the sending and receiving populations so that we’re not, you know, we’re not creating some of those issues.
